Size the market, scan the R&D horizon, and compare prices with confidence, using real-world data and consensus forecasts out to 2030. Get information straight from the source – government and company reports. Dig into all the details and make evidence-based decisions that put you ahead.
Access consensus forecasts for key branded drugs at a European country level. Map future trends of key marketed drugs and pipeline assets. Profile in-line products, identify new assets, and measure their impact on key therapy areas.
Explore the full pipeline of R&D products launching in the European market. Compare R&D product performance, mapping uptake trends and drivers across key European markets.
Analyze ex-factory pricing data for Germany, France, Italy, England, Poland, Spain, and other key markets. Quickly assess new assets using price/DDD benchmark data, and easily carry out comparative analysis across EU-6 countries.
Get in touch with our team to explore the right solutions for your business.
